Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 118853-60-4 | MDL No. : | MFCD10697802 |
Formula : | C6H7N3O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MFQOPTGQOOILCR-UHFFFAOYSA-N |
M.W : | 153.14 | Pubchem ID : | 44558107 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 37.72 |
TPSA : | 78.1 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.83 cm/s |
Log Po/w (iLOGP) : | 1.0 |
Log Po/w (XLOGP3) : | -0.84 |
Log Po/w (WLOGP) : | -0.15 |
Log Po/w (MLOGP) : | -1.03 |
Log Po/w (SILICOS-IT) : | 0.02 |
Consensus Log Po/w : | -0.2 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.53 |
Solubility : | 45.0 mg/ml ; 0.294 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.32 |
Solubility : | 73.4 mg/ml ; 0.479 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.35 |
Solubility : | 6.78 mg/ml ; 0.0443 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.88 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82.4% | Stage #1: With sodium azide; triphenylphosphine In dimethyl sulfoxide at 120℃; for 4 h; Stage #2: With hydrogenchloride In water; dimethyl sulfoxide at 120℃; for 12 h; |
Methyl 6-(chloropyrazine)-2-carboxylate (13) (2g, 0.0115mmol) was dissolved in 80mL of 87 DMSO. 88 Sodium azide (3g, 0.0463mmol) and 39 triphenylphosphene (4.6g, 0.1738mmol) were added and refluxed at 120°C for 4h. 20mL of 1N 89 HCl was added and the reaction was continued at 120°C for 2h. The mixture was cooled and neutralized by aqueous NaHCO3 solution and 131 product was extracted in ethyl acetate, dried with Na2SO4 which was then concentrated and dried with n-pentane to get 1.4g of compound 14 as yellow solid (yield 82.4percent). 1H NMR (400MHz, DMSO‑d6) δ 8.28–8.27 (m, 1H), 8.07 (s, 1H), 6.90 (s, 2H), 3.84 (s, 3H). C6H7N3O2 [M]: 153.14; MS (ESI) m/z: [M+H]+: 154.05 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | at 85℃; for 5 h; Large scale | A solution of 6-chloro-2-pyrazinamine (4 kg, 31 mol, 1.00 equiv), Et3N (4.7 kg,46.5 mol, 1.50 equiv), Pd(OAc)2 (139 g, 0.62mo1, 0.02 equiv), dppf (343 g, 0.62 mol, 0.02equiv) in methanol (60 L) was placed in a 100 L pressure tank reactor(10 atm).The resulting solution was allowed to react for 5 h while maintaining the temperature at 85°C. The reaction progress was monitored by TLC (DCM: MeOH = 20: 1) until the starting material was consumed completely, and cooled to room temperature. The resulting mixture was concentrated under vacuum. The residue was washed with water 50 L. Thefilter was collected and dried. The product (3.8 kg, purity = 95 percent, 80 percent yield)obtained as a pale brown solid.1H-NIVIR (300 MHz, DMSO-d6) : 8.27(1H, s), 8.06(1H, s), 6.87(2H, b), 3.84(3H, s). LC-MS: m / z = 154(M+H) +. |
[ 54013-06-8 ]
Ethyl 5-aminopyrazine-2-carboxylate
Similarity: 0.96
[ 27825-20-3 ]
Methyl 3-Hydroxy-2-pyrazinecarboxylate
Similarity: 0.78
[ 13924-95-3 ]
Methyl 5-hydroxypyrazine-2-carboxylate
Similarity: 0.77
[ 54013-06-8 ]
Ethyl 5-aminopyrazine-2-carboxylate
Similarity: 0.96
[ 61442-38-4 ]
6-Aminopyrazine-2-carboxylic acid
Similarity: 0.88
[ 40262-53-1 ]
6-(Dimethylamino)pyrazine-2-carboxylic acid
Similarity: 0.75
[ 16298-03-6 ]
Methyl 2-aminopyrazine-3-carboxylate
Similarity: 0.73
[ 1458-01-1 ]
Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate
Similarity: 0.71
[ 54013-06-8 ]
Ethyl 5-aminopyrazine-2-carboxylate
Similarity: 0.96
[ 61442-38-4 ]
6-Aminopyrazine-2-carboxylic acid
Similarity: 0.88
[ 27825-20-3 ]
Methyl 3-Hydroxy-2-pyrazinecarboxylate
Similarity: 0.78